Výsledky vyhledávání - "Michael N. Potter"

Akademický článek

Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors

Autor: Esteban Arrieta-Bolaños, Neema P. Mayor, Steven G.E. Marsh, J. Alejandro Madrigal, Jane F. Apperley, Keiren Kirkland, Stephen Mackinnon, David I. Marks, Grant McQuaker, Julia Perry, Michael N. Potter, Nigel H. Russell, Kirsty Thomson, Bronwen E. Shaw

Publikováno v: Haematologica, Vol 101, Iss 3 (2016)

Transforming growth factor β-1, encoded by the TGFB1 gene, is a cytokine that plays a central role in many physiological and pathogenic processes. We have sequenced TGFB1 regulatory region and assigned allelic genotypes in a large cohort of hematopo

Externí odkaz: https://doaj.org/article/10211a0729b0476e918d0ed826e11fb2

Zobrazit plný text záznamu

Akademický článek

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Publikováno v: Haematologica, Vol 100, Iss 3 (2015)

This study aimed to determine the impact of tyrosine kinase inhibitors given pre- and post-allogeneic stem cell transplantation on long-term outcome of patients allografted for Philadelphia chromosome-positive acute lymphoblastic leukemia. This retro

Externí odkaz: https://doaj.org/article/9ad982de38d0479d80ddde912a519cbe

Zobrazit plný text záznamu

Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival:A Retrospective Study

Publikováno v: Mayor, N P, Hayhurst, J D, Turner, T R, Szydlo, R M, Shaw, B E, Bultitude, W P, Sayno, J R, Tavarozzi, F, Latham, K, Anthias, C, Robinson, J, Braund, H, Danby, R, Perry, J, Wilson, M C, Bloor, A J, McQuaker, I G, MacKinnon, S, Marks, D I, Pagliuca, A, Potter, M N, Potter, V T, Russell, N H, Thomson, K J, Madrigal, J A & Marsh, S G E 2019, ' Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival : A Retrospective Study ', Biology of Blood and Marrow Transplantation, vol. 25, no. 3, pp. 443-450 . https://doi.org/10.1016/j.bbmt.2018.12.768

HLA matching at an allelic-level resolution for volunteer unrelated donor (VUD) hematopoietic cell transplantation (HCT) results in improved survival and fewer post-transplant complications. Limitations in typing technologies used for the hyperpolymo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c13ddb11dab0ced42693786dffb69747
https://research-information.bris.ac.uk/en/publications/a23dd8f9-ebb1-47ae-b832-9eda893485a3

Zobrazit plný text záznamu

The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study

Autor: David C. Linch, David I. Marks, Marie Wilson, Maria H. Gilleece, Stephen Mackinnon, John G. Gribben, K. Towlson, Majid Kazmi, Michael N. Potter, Rachel Pearce

Publikováno v: Hematology. 13:119-127

Lymphoplasmacytic lymphoma (LL) is incurable by standard therapy (median survival: 60 months). UK transplant registry data 1984-2003 identified 18 cases of histologically verified LL (median age: 50 years, range: 38-58 years). Nine patients received

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee6975fe62a8ed67d234dd8160b5e1d0
https://doi.org/10.1179/102453308x315915

Zobrazit plný text záznamu

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation

Autor: R. L. Powles, Jennifer Byrne, Rajesh Chopra, S Koblinger, Bhawna Sirohi, H. G. Prentice, Michael N. Potter, Nigel H. Russell

Publikováno v: Bone Marrow Transplantation. 38:47-51

This open-label, dose-escalation study assessed the maximum tolerated dose (MTD) of the new antifungal micafungin in patients undergoing haematopoietic stem cell transplantation (HSCT). Participants received 3, 4, 6 or 8 mg/kg/day micafungin intraven

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dfbdc0b60433ea87ee236bdbb5abd3a
https://doi.org/10.1038/sj.bmt.1705398

Zobrazit plný text záznamu

From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature

Autor: Armando Gabrielli, Philip N. Hawkins, Christopher P. Denton, Geraldine Brough, Carol M. Black, Constantinos P. Anastassiades, Michael N. Potter, Magdalena Dziadzio

Publikováno v: Clinical Rheumatology. 25:3-15

Scleredema (also called scleredema of Buschke) is a fibromucinous connective tissue disorder of unknown cause that belongs to a group of scleroderma-like disorders. We report the case of a 64-year-old lady with long-standing scleredema, associated wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b206ff525d131170ba1062a848223b1
https://doi.org/10.1007/s10067-004-1076-3

Zobrazit plný text záznamu

Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation

Autor: Sge Marsh, F. Petronzelli, J. A. Madrigal, Bronwen E. Shaw, C. Smith, Julia G. Bodmer, Michael N. Potter, Neema P. Mayor, H. Maldonado

Publikováno v: Tissue Antigens. 63:401-411

Sustained myeloid engraftment is an important determinant of outcome in hematopoietic stem cell transplantation (HSCT). Human tumor necrosis factor (TNF)-alpha is encoded by a gene, TNFA, located in the class III region of the major histocompatibilit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f06a8fcdbe75b10173b8fe7d9a6bcd0
https://doi.org/10.1111/j.0001-2815.2004.00218.x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání